Clinical Trials Logo

Filter by:
NCT ID: NCT01548027 Completed - Child Clinical Trials

Surgical Transversus Abdominis Plane Block in Pediatric Patients

TAP
Start date: July 2012
Phase: N/A
Study type: Interventional

The objective of this study to determine the effect of surgical transversus abdominis plane block and local infiltration for postoperative pain control in major abdominal surgery compare with control group.

NCT ID: NCT01547221 Completed - Otomycosis Clinical Trials

Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients

Start date: March 2012
Phase: N/A
Study type: Interventional

Otomycosis is a superficial fungal infection of the external ear canal. Patients should be treated with cleaning fungal debris combined with topical antifungal agent. There is wide range of topical antifungal agents. However, there is still no consensus of the most effective topical antifungal agents in treatment otomycosis is still lacking. According to Thai National List of essential medicines for topical antifugal agents are: - acetic acid (2% in aqueous and 2% in 70% isopropyl alcohol) - boric acid (3% in isopropyl alcohol) - gentian violet - clotrimazole ear drop. But from literature review, there is no comparative study between boric acid and clotrimazole solution before. Objective is to compare the clinical effectiveness and adverse events of 1% clotrimazole solution versus 3% boric acid in 70% alcohol for the treatment of otomycosis.

NCT ID: NCT01546961 Completed - Vivax Malaria Clinical Trials

Chloroquine Population Pharmacokinetics in Pre and Post-partum Women

KCP
Start date: June 2011
Phase: N/A
Study type: Interventional

For the treatment of P.vivax the standard treatment is chloroquine. There is a growing body of evidence suggesting that pregnant women may require different doses of drugs, including antimalarials due to the physiological changes of pregnancy. It is important that any drug used in pregnant women it is given at the correct dose. The only way to evaluate this is by pharmacokinetic studies. The investigators propose to evaluate the pharmacokinetics of chloroquine when use to treat P.vivax in the 2nd or 3rd trimester of pregnancy. The same evaluation in the same woman post-partum is required as a control.

NCT ID: NCT01546233 Completed - Lung Cancer Clinical Trials

Multidisciplinary Education in Lung Cancer Patients Who Receiving Chemotherapy Treatment

Start date: March 2012
Phase: N/A
Study type: Observational

The purpose of this study is to compare the fatigue in lung cancer patients receiving chemotherapy treatment, between the education programme in self-care a multidisciplinary with the group who received standard care.

NCT ID: NCT01543945 Completed - Clinical trials for Postoperative Nausea and Vomiting

Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic Laparoscopy

Start date: March 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the incidence of Postoperative nausea and vomiting between the intervention group who received multimodal antiemetic management and the control group who did not get this protocol.

NCT ID: NCT01541215 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes

Ellipseā„¢
Start date: November 13, 2012
Phase: Phase 3
Study type: Interventional

This trial is conducted globally. The aim of this trial is to assess the efficacy and safety of liraglutide in the paediatric population in order to potentially address the unmet need for treatment of children and adolescents with type 2 diabetes.

NCT ID: NCT01540084 Completed - Clinical trials for Disorders of Gallbladder, Biliary Tract and Pancreas

Cocktail Sedation Containing Propofol Versus Conventional Sedation for Endoscopic Retrograde Cholangiopancreatography (ERCP)

Start date: December 2006
Phase: Phase 4
Study type: Interventional

Endoscopic retrograde cholangiopancreatography (ERCP) practically requires moderate to deep sedation by a combination of benzodiazepine and opioid. Propofol as a sole agent may cause oversedation. A combination (cocktail) of infused propofol, meperidine, and midazolam can reduce the dosage of propofol and may result in a lower risk of oversedation. The investigators prospectively compare the efficacy, recovery time, patient satisfactory, and side effects between cocktail and conventional sedations in patients undergoing ERCP.

NCT ID: NCT01539980 Completed - Pain, Intractable Clinical Trials

Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment

Start date: August 2012
Phase: Phase 1/Phase 2
Study type: Interventional

1. Silk sericin wound dressing may reduce time for complete epithelialisation of split-thickness skin graft donor sites compared to Bactigras®. 2. Silk sericin wound dressing may reduce pain level at split-thickness skin graft donor sites compared to Bactigras® . 3. Silk sericin wound dressing may not cause split-thickness skin graft donor sites infection as compared to Bactigras®. 4. Split-thickness skin graft donor sites which treat by silk sericin wound dressing may not cause significant adverse events.

NCT ID: NCT01538940 Completed - Influenza Clinical Trials

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

Start date: November 1, 2011
Phase: Phase 4
Study type: Interventional

This study will assess the efficacy of a new intradermal formulation of the trivalent inactivated influenza vaccine compared to the standard intramuscular vaccine in HIV-infected men who have sex with men in Bangkok, Thailand. Relative efficacy of the two different formulations of influenza vaccine will be assessed by comparing immunologic responses to vaccine between the two study arms.

NCT ID: NCT01531348 Completed - Clinical trials for Retinitis Pigmentosa

Intravitreal Injection of MSCs in Retinitis Pigmentosa

Start date: April 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the feasibility and safety of adult human bone marrow-derived mesenchymal stem cells by intravitreal injection in patients with retinitis pigmentosa.